OCI-Hanmi merger aims for Korean version of Bayer
OCI Group, a chemical, solar power and electric car battery material maker, looks to merge with drugmaker Hanmi Pharmaceutical Group, as the two entities seek business synergies to create the Korean version of Bayer, the German chemicals-to-pharmaceuticals giant. On Friday, OCI Holdings and Hanmi Science, the holding units of the two entities, made a surprise announcement that they were merging through a stock acquis...
Bukwang Pharm Hanmi Pharmaceutical Group Oci Group Fair Trade Commission Hanmi Science President Lim Ju Hyun
Source: koreaherald.com